Registration status | All trials (n = 473) | Investigator-sponsored trials (n = 342) | Industry-sponsored trials (n = 131) |
---|---|---|---|
Registered (n, %) | 432 (91.3%) | 306 (89.5%) | 126 (96.2%) |
Prospectivelya | 326 (68.9%) | 213 (62.3%)c | 113 (86.3%) |
Prospectively 30b | 371 (78.4%)b | 249 (72.8%)c | 122 (93.1%) |